[
  {
    "ts": null,
    "headline": "CVS Q1 Earnings Call: Guidance Raised Amid Segment Shifts and Pharmacy Innovation",
    "summary": "Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q1 CY2025, with sales up 7% year on year to $94.59 billion. Its non-GAAP profit of $2.25 per share was 34.6% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=6a7115cfd915ea6184f6ea468cf42a32c106a3638c50d8483ff2d08fb41acead",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747260605,
      "headline": "CVS Q1 Earnings Call: Guidance Raised Amid Segment Shifts and Pharmacy Innovation",
      "id": 134465785,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q1 CY2025, with sales up 7% year on year to $94.59 billion. Its non-GAAP profit of $2.25 per share was 34.6% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=6a7115cfd915ea6184f6ea468cf42a32c106a3638c50d8483ff2d08fb41acead"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?",
    "summary": "CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering high medication adherence.",
    "url": "https://finnhub.io/api/news?id=47517c685d8fe254c623c63d8828e36daf1f92f705496c07a50e0f13645ad8c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747249200,
      "headline": "CVS Health Stock Rallies 38% in May: Is it a Buy Amid PBM Pressure?",
      "id": 134461154,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS' pharmacy segment continues to lead the industry, processing over 1.7 billion prescriptions annually while delivering high medication adherence.",
      "url": "https://finnhub.io/api/news?id=47517c685d8fe254c623c63d8828e36daf1f92f705496c07a50e0f13645ad8c3"
    }
  },
  {
    "ts": null,
    "headline": "Why the UnitedHealth leadership shake-up is giving Wall Street the chills",
    "summary": "UnitedHealth Group's sudden CEO shake-up has left investors wary as they were already souring on the stock.",
    "url": "https://finnhub.io/api/news?id=e89eb0b7774ac897ae320bd02311db33a8623eb91e431351b5b128e93ae8dfc7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747235761,
      "headline": "Why the UnitedHealth leadership shake-up is giving Wall Street the chills",
      "id": 134460772,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "UnitedHealth Group's sudden CEO shake-up has left investors wary as they were already souring on the stock.",
      "url": "https://finnhub.io/api/news?id=e89eb0b7774ac897ae320bd02311db33a8623eb91e431351b5b128e93ae8dfc7"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna",
    "summary": "Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.",
    "url": "https://finnhub.io/api/news?id=71b06c9802ba32c3efeb1275638679d3b784e16acd1c56670b59adf5f109f919",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747229552,
      "headline": "Novo Nordisk's latest bet on obesity pills: $2.2 billion for biotech Septerna",
      "id": 134460715,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Novo Nordisk (NVO) announced a new $2.2 billion deal with San Francisco-based biotech Sapterna (SEPN) for obesity pills.",
      "url": "https://finnhub.io/api/news?id=71b06c9802ba32c3efeb1275638679d3b784e16acd1c56670b59adf5f109f919"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Basic Value V.I. Fund Q1 2025 Commentary",
    "summary": "BlackRock Basic Value V.I. Fund posted a return of 3.86% (Class I shares) for the first quarter of 2025. Read more here.",
    "url": "https://finnhub.io/api/news?id=5ef9d5c3c0d26c3f41c193b8e64c234f18a3cb5feb03a2c55296133bcbeaf401",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747225980,
      "headline": "BlackRock Basic Value V.I. Fund Q1 2025 Commentary",
      "id": 134440156,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182047027/image_2182047027.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "BlackRock Basic Value V.I. Fund posted a return of 3.86% (Class I shares) for the first quarter of 2025. Read more here.",
      "url": "https://finnhub.io/api/news?id=5ef9d5c3c0d26c3f41c193b8e64c234f18a3cb5feb03a2c55296133bcbeaf401"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer",
    "summary": "StoneCo, Centene, CVS Health and Pfizer have been highlighted in this Screen of The Week article.",
    "url": "https://finnhub.io/api/news?id=420d918d90b0468a522f750f52ad9dc45c4d0a1151f038670dfd01d413896ae8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747223160,
      "headline": "Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer",
      "id": 134461054,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "StoneCo, Centene, CVS Health and Pfizer have been highlighted in this Screen of The Week article.",
      "url": "https://finnhub.io/api/news?id=420d918d90b0468a522f750f52ad9dc45c4d0a1151f038670dfd01d413896ae8"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Loses CEO, Withdraws Guidance: Under Siege, Destination Unknown",
    "summary": "UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs. Click to read why UNH is a Hold.",
    "url": "https://finnhub.io/api/news?id=639e8c440d3a8ef8f8ca71cecdfff7619e62c587a3cdd834164083d32417e1de",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747217645,
      "headline": "UnitedHealth Loses CEO, Withdraws Guidance: Under Siege, Destination Unknown",
      "id": 134436260,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182356607/image_2182356607.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs. Click to read why UNH is a Hold.",
      "url": "https://finnhub.io/api/news?id=639e8c440d3a8ef8f8ca71cecdfff7619e62c587a3cdd834164083d32417e1de"
    }
  },
  {
    "ts": null,
    "headline": "Why CVS Health Corporation (CVS) Declined on Tuesday",
    "summary": "We recently published an article titled Massive Sell-Offs Just Hit These 10 Stocks Today. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other stocks. Wall Street’s main indices finished mixed on Tuesday, as investors digested the country’s latest inflation figures, which came out lower than […]",
    "url": "https://finnhub.io/api/news?id=b65764fa613c0ce3cbc9ab0cc48c7d55c4586e4e2f3ebccce67745a2bbf26cba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747216639,
      "headline": "Why CVS Health Corporation (CVS) Declined on Tuesday",
      "id": 134461158,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "We recently published an article titled Massive Sell-Offs Just Hit These 10 Stocks Today. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other stocks. Wall Street’s main indices finished mixed on Tuesday, as investors digested the country’s latest inflation figures, which came out lower than […]",
      "url": "https://finnhub.io/api/news?id=b65764fa613c0ce3cbc9ab0cc48c7d55c4586e4e2f3ebccce67745a2bbf26cba"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Stock Has Dropped 40% This Year. These Analysts Are Finally Downgrading the Shares.",
    "summary": "UnitedHealth Stock Has Dropped 40% This Year. These Analysts Are Finally Downgrading the Shares.",
    "url": "https://finnhub.io/api/news?id=714dd1b9b9a7919093197a05bcdfa1beef9e401915abcdd1c4895da4b762caef",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747215540,
      "headline": "UnitedHealth Stock Has Dropped 40% This Year. These Analysts Are Finally Downgrading the Shares.",
      "id": 134438020,
      "image": "",
      "related": "CVS",
      "source": "MarketWatch",
      "summary": "UnitedHealth Stock Has Dropped 40% This Year. These Analysts Are Finally Downgrading the Shares.",
      "url": "https://finnhub.io/api/news?id=714dd1b9b9a7919093197a05bcdfa1beef9e401915abcdd1c4895da4b762caef"
    }
  },
  {
    "ts": null,
    "headline": "Why UnitedHealth’s Blowup May Be More Isolated Than Investors Think",
    "summary": "Surging medical costs and regulatory changes hit UnitedHealth, but rivals such as Humana and CVS look better positioned.",
    "url": "https://finnhub.io/api/news?id=fcac3a2cceeda3278f0d6bb0d27010ebea5926aa1f21089daafa964f93aa190d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747215000,
      "headline": "Why UnitedHealth’s Blowup May Be More Isolated Than Investors Think",
      "id": 134461159,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Surging medical costs and regulatory changes hit UnitedHealth, but rivals such as Humana and CVS look better positioned.",
      "url": "https://finnhub.io/api/news?id=fcac3a2cceeda3278f0d6bb0d27010ebea5926aa1f21089daafa964f93aa190d"
    }
  },
  {
    "ts": null,
    "headline": "Health Insurance Providers Stocks Q1 Highlights: Molina Healthcare (NYSE:MOH)",
    "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Molina Healthcare (NYSE:MOH) and its peers.",
    "url": "https://finnhub.io/api/news?id=5e573d9519573ba80f0a8cbd602196583d5f07d937cb498f4772630760a2d61d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747193555,
      "headline": "Health Insurance Providers Stocks Q1 Highlights: Molina Healthcare (NYSE:MOH)",
      "id": 134461160,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Molina Healthcare (NYSE:MOH) and its peers.",
      "url": "https://finnhub.io/api/news?id=5e573d9519573ba80f0a8cbd602196583d5f07d937cb498f4772630760a2d61d"
    }
  }
]